HSBC Holdings
NPCE icon

HSBC Holdings’s Neuropace NPCE Stock Holding History

HSBC Holdings’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$381K Sell
29,748
-7,899
-21% -$119K ﹤0.01% 2341
2025
Q4 		$579K Sell
37,647
-16,907
-31% -$226K ﹤0.01% 2240
2025
Q3 		$565K Sell
54,554
-4,694
-8% -$44.3K ﹤0.01% 2042
2025
Q2 		$661K Buy
+59,248
New +$741K ﹤0.01% 2003

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

HSBC Holdings's NPCE Position: Q1 2026 in Review

HSBC Holdings reduced its Neuropace (NPCE) stake by 21% in Q1 2026, selling an estimated $119K and leaving 29,748 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #2341.

HSBC Holdings first reported a position in NPCE in Q2 2025 and has held it in 4 quarters since. The position peaked at $661K in Q2 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • HSBC Holdings held 29,748 shares of Neuropace worth $381K as of Q1 2026.
  • HSBC Holdings sold 7,899 Neuropace shares in Q1 2026, an estimated $119K.
  • Neuropace made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2341 holding.
  • HSBC Holdings first reported a position in Neuropace in Q2 2025 and has held it in 4 quarters since.
  • HSBC Holdings's Neuropace position peaked at $661K in Q2 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.